Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Tennessee
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Tennessee
4 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Tennessee.
A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- GC2402 Study Site 111, Cordova
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07540221A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- University Neurology, Knoxville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07091630A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- University Neurology, Knoxville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06920004A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Cinical Study Site, Nashville
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 28, 2026 · NCT06858579From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.